GAMBARAN JUMLAH SKS MATA KULIAH PERGURUAN TINGGI FARMASI INDONESIA YANG MENDUKUNG PENGGUNAAN OBAT YANG RASIONAL

Authors

  • Hendy Ristiono
  • Sri Suryawati
  • Sulanto Saleh Danu

DOI:

https://doi.org/10.12928/pharmaciana.v5i2.2674

Keywords:

rational drug use, the Indonesian pharmacy college of cummulative credit course, PRDU INRUD

Abstract

According to World  Health Organization (WHO), there are two major steps as a commitment to make changes in the implementation of pharmacy practice that are national drug policy and learning system changes in pharmacy education. The aim of the research was to obtain the cummulative credit overview in college of pharmacy in Indonesia that supporting Rational Drug Use based on promotion rational drug use (PRDU) and International network  rational use of drug (INRUD). This study used a analytic descriptive design. The study was located in some colleges of pharmacy in Indonesia. Data was collected through observation of the recent curriculum used in the Indonesian college of pharmacy. Research were conducted by giving a questionnaire on the rational drug use topic in the curriculum and in-depth interviews with the dean or faculties appointed by the dean. The number of credits developed by 21 colleges of pharmacy as respondents have in between 140-158 credits. Median number of credits developed by C accreditation level are more than A and B accreditation level. Three of  A accreditation level of colleges have number of credits in between 66-171 credits and a college with B accreditation level as much as 36.9 credits. Whereas in total of credits semester that support the RDU in Community and Clinical Pharmacy (CCP) interests has more than the non-CCP interests.

Downloads

Published

2015-11-30

Issue

Vol. 5 No. 2 (2015): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.